A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Caroline Labib, PharmD
TORL Biotherapeutics, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Health Network, Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Erica TsangRecruiting - Mcgill University Health Centre
Montreal, Quebec, Canada
Ramy Saleh, MDRecruiting
- Mayo Clinic Phoenix
Phoenix, Arizona, United States
Mohamad Sonbol, MDRecruiting - Providence Medical Foundation
Fullerton, California, United States
Recruiting - Ucla - Jccc Clinical Research Unit
Los Angeles, California, United States
Recruiting - Torrance Memorial Physician Network
Torrance, California, United States
Justin Tiulim, MDRecruiting - Mayo Clinic Jacksonville
Jacksonville, Florida, United States
Yanyan Lou, MDRecruiting - Florida Cancer Specialists Lake Nona Drug Development Unit
Orlando, Florida, United States
Cesar Perez, MDRecruiting - Mayo Clinic Rochester
Rochester, Minnesota, United States
Andrea Wahner-Hendrickson, MDRecruiting - Virginia Cancer Specialists
Lexington, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Dec 2023
- Primary completion
- 31 Oct 2025
- Completion
- 31 Oct 2026
- Last update posted
- 4 Mar 2025
- Registered enrollment
- 70
- Registry id
- NCT06005740
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.